Publicação: How can micelle systems be rebuilt by a heating process?
dc.contributor.author | da Silva-Filho, Miguel Adelino | |
dc.contributor.author | Siqueira, Scheyla Daniela Vieira da Silva | |
dc.contributor.author | Freire, Larissa Bandeira | |
dc.contributor.author | de Araújo, Ivonete Batista | |
dc.contributor.author | de Holandae e Silva, Káttya Gyselle | |
dc.contributor.author | da Medeiros, Aldo Cunha | |
dc.contributor.author | Araújo-Filho, Irami | |
dc.contributor.author | de Oliveira, Anselmo Gomes [UNESP] | |
dc.contributor.author | do Egito, Eryvaldo Sócrates Tabosa | |
dc.contributor.institution | Federal University of rio grande do Norte (UFrN) | |
dc.contributor.institution | UFrN | |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
dc.date.accessioned | 2022-04-29T02:43:14Z | |
dc.date.available | 2022-04-29T02:43:14Z | |
dc.date.issued | 2012-02-10 | |
dc.description.abstract | The aim of this work was to evaluate how an aqueous micellar system containing Amphotericin B (AmB) and sodium deoxycholate (DOC) can be rebuilt after heating treatment. Also, a review of the literature on the physicochemical and biological properties of this new system was conducted. Heated (AmB-DOC-H) and unheated (AmB-DOC) micelles were then diluted at four different concentrations (50 mg. L -1, 5 mg. L -1, 0.5 mg. L -1, and 0.05 mg. L -1) to perform physicochemical studies and a pharmacotoxicity assay, in which two cell models were used for the in vitro experiments: red blood cells (RBC) from human donors and Candida parapsilosis (Cp). While potassium (K +) and hemoglobin leakage from RBC were the parameters used to evaluate acute and chronic toxicity, respectively, the effcacy of AmB-DOC and AmB-DOC-H were assessed by K + leakage and cell survival rate from Cp. The spectral study revealed a slight change in the AmB-DOC aggregate peak from 327 nm to 323 nm, which is the peak for AmB-DOC-H. Although AmB-DOC and AmB-DOC-H exhibited different behavior for hemoglobin leakage, AmB-DOC produced higher leakage than AmB-DOC-H at high concentrations (from 5 mg. L -1). For K + leakage, both AmB-DOC and AmB-DOC-H showed a similar profle for both cell models, RBC and Cp (P < 0.05). AmB-DOC-H and AmB-DOC also revealed a similar profle of activity against Cp with an equivalent survival rate. In short, AmB-DOC-H showed much less toxicity than AmB-DOC, but remained as active as AmB-DOC against fungal cells. The results highlight the importance of this new procedure as a simple, inexpensive, and safe way to produce a new kind of micelle system for the treatment of systemic fungal infections. © 2012 Silva-Filho et al. | en |
dc.description.affiliation | Dispersed Systems Laboratory Federal University of rio grande do Norte (UFrN), Rio grande do Norte, 8948 Natal | |
dc.description.affiliation | Department of Pharmacy UFrN, Natal, Rio grande do Norte | |
dc.description.affiliation | Department of experimental Surgery UFrN, Natal, rio grande do Norte | |
dc.description.affiliation | Department of Drugs and Medicines College of Pharmaceutical Sciences (UNeSP), Araraquara, São Paulo | |
dc.description.affiliationUnesp | Department of Drugs and Medicines College of Pharmaceutical Sciences (UNeSP), Araraquara, São Paulo | |
dc.format.extent | 141-150 | |
dc.identifier.citation | International Journal of Nanomedicine, v. 7, p. 141-150. | |
dc.identifier.issn | 1176-9114 | |
dc.identifier.issn | 1178-2013 | |
dc.identifier.scopus | 2-s2.0-84856639968 | |
dc.identifier.uri | http://hdl.handle.net/11449/226699 | |
dc.language.iso | eng | |
dc.relation.ispartof | International Journal of Nanomedicine | |
dc.source | Scopus | |
dc.subject | Micelles | |
dc.subject | Nanotechnology | |
dc.subject | Pre-heated amphotericin B | |
dc.subject | Super-aggregates | |
dc.title | How can micelle systems be rebuilt by a heating process? | en |
dc.type | Artigo | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isDepartmentOfPublication.latestForDiscovery | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
unesp.department | Fármacos e Medicamentos - FCF | pt |